162 related articles for article (PubMed ID: 32984030)
21. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
Meng Y; Yu J; Zhu M; Zhou J; Li N; Liu F; Zhang H; Fang X; Li J; Feng X; Wang L; Jiang H; Lu J; Shao C; Bian Y
Abdom Radiol (NY); 2022 Aug; 47(8):2822-2834. PubMed ID: 35451626
[TBL] [Abstract][Full Text] [Related]
22. Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma.
Liu P; Gu Q; Hu X; Tan X; Liu J; Xie A; Huang F
J Xray Sci Technol; 2020; 28(6):1113-1121. PubMed ID: 33074215
[TBL] [Abstract][Full Text] [Related]
23. Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact.
Jiang Y; Che S; Ma S; Liu X; Guo Y; Liu A; Li G; Li Z
Cancer Imaging; 2021 Jan; 21(1):1. PubMed ID: 33407884
[TBL] [Abstract][Full Text] [Related]
24. Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis.
Shi H; Wei Y; Cheng S; Lu Z; Zhang K; Jiang K; Xu Q
Pancreatology; 2021 Jun; 21(4):731-737. PubMed ID: 33678581
[TBL] [Abstract][Full Text] [Related]
25. CT-Based Radiomics Signature for the Preoperative Discrimination Between Head and Neck Squamous Cell Carcinoma Grades.
Wu W; Ye J; Wang Q; Luo J; Xu S
Front Oncol; 2019; 9():821. PubMed ID: 31544063
[No Abstract] [Full Text] [Related]
26. A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma.
Gao J; Han F; Jin Y; Wang X; Zhang J
Front Oncol; 2020; 10():1654. PubMed ID: 32974205
[TBL] [Abstract][Full Text] [Related]
27. CT Radiomics Features in Differentiation of Focal-Type Autoimmune Pancreatitis from Pancreatic Ductal Adenocarcinoma: A Propensity Score Analysis.
Li J; Liu F; Fang X; Cao K; Meng Y; Zhang H; Yu J; Feng X; Li Q; Liu Y; Wang L; Jiang H; Shao C; Lu J; Bian Y
Acad Radiol; 2022 Mar; 29(3):358-366. PubMed ID: 34108115
[TBL] [Abstract][Full Text] [Related]
28. CT-measured body composition radiomics predict lymph node metastasis in localized pancreatic ductal adenocarcinoma.
Gu Q; He M; He Y; Dai A; Liu J; Chen X; Liu P
Discov Oncol; 2023 Feb; 14(1):16. PubMed ID: 36735166
[TBL] [Abstract][Full Text] [Related]
29. Liver metastases in pancreatic ductal adenocarcinoma: a predictive model based on CT texture analysis.
De Robertis R; Geraci L; Tomaiuolo L; Bortoli L; Beleù A; Malleo G; D'Onofrio M
Radiol Med; 2022 Oct; 127(10):1079-1084. PubMed ID: 36057929
[TBL] [Abstract][Full Text] [Related]
30. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
[TBL] [Abstract][Full Text] [Related]
31. Compute Tomography Radiomics Analysis on Whole Pancreas Between Healthy Individual and Pancreatic Ductal Adenocarcinoma Patients: Uncertainty Analysis and Predictive Modeling.
Wang S; Lin C; Kolomaya A; Ostdiek-Wille GP; Wong J; Cheng X; Lei Y; Liu C
Technol Cancer Res Treat; 2022; 21():15330338221126869. PubMed ID: 36184987
[TBL] [Abstract][Full Text] [Related]
32. CT Radiomics and Machine-Learning Models for Predicting Tumor-Stroma Ratio in Patients With Pancreatic Ductal Adenocarcinoma.
Meng Y; Zhang H; Li Q; Liu F; Fang X; Li J; Yu J; Feng X; Zhu M; Li N; Jing G; Wang L; Ma C; Lu J; Bian Y; Shao C
Front Oncol; 2021; 11():707288. PubMed ID: 34820324
[TBL] [Abstract][Full Text] [Related]
33. Radiomics models based on multi-sequence MRI for preoperative evaluation of MUC4 status in pancreatic ductal adenocarcinoma: a preliminary study.
Deng Y; Li Y; Wu JL; Zhou T; Tang MY; Chen Y; Zuo HD; Tang W; Chen TW; Zhang XM
Quant Imaging Med Surg; 2022 Nov; 12(11):5129-5139. PubMed ID: 36330180
[TBL] [Abstract][Full Text] [Related]
34. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
[TBL] [Abstract][Full Text] [Related]
36. Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing.
Choi MH; Yoon SB; Lee YJ; Jung ES; Pak S; Han D; Nickel D
Front Oncol; 2024; 14():1304187. PubMed ID: 38525415
[TBL] [Abstract][Full Text] [Related]
37. Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule.
Fan L; Fang M; Li Z; Tu W; Wang S; Chen W; Tian J; Dong D; Liu S
Eur Radiol; 2019 Feb; 29(2):889-897. PubMed ID: 29967956
[TBL] [Abstract][Full Text] [Related]
38. Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on
Xing H; Hao Z; Zhu W; Sun D; Ding J; Zhang H; Liu Y; Huo L
EJNMMI Res; 2021 Feb; 11(1):19. PubMed ID: 33630176
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Multiple Radiomics Models for Identifying Histological Grade of Pancreatic Ductal Adenocarcinoma Preoperatively Based on Multiphasic Contrast-Enhanced Computed Tomography: A Two-Center Study in Southwest China.
Liao H; Li Y; Yang Y; Liu H; Zhang J; Liang H; Yan G; Liu Y
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010267
[TBL] [Abstract][Full Text] [Related]
40. Radiomics analysis of multicenter CT images for discriminating mucinous adenocarcinoma from nomucinous adenocarcinoma in rectal cancer and comparison with conventional CT values.
Ge YX; Li J; Zhang JQ; Duan SF; Liu YK; Hu SD
J Xray Sci Technol; 2020; 28(2):285-297. PubMed ID: 32116286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
